Bovie Medical (BVX) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Bovie Medical Corporation Reports First Quarter 2016 Results
May 11, 2016 7:00 AM EDTFirst Quarter Highlights
Total revenue increased 26.9% Gross margin was 42.7% J-Plasma® revenues increased 25.8% year-on-year; Positive trends in operating metrics continued in Q1 Company on track for 20% revenue growth for full year 2016CLEARWATER, Fla.--(BUSINESS WIRE)-- Bovie Medical Corporation (NYSEMKT: BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced results for the first quarter ended March 31, 2016.
Management... More
